Search Results < Psychiatry

205 results

News
Fighting Breast and Ovarian Cancer With a Lupus Antibody
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
26 Sep 2022
News
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
17 Jun 2019
News
Better Science, Better Lives for Women and Men: Q&A with Carolyn Mazure
WHRY Director Carolyn M. Mazure discusses how we are at a critical point, and the scientific community needs to decide if it will embrace true transformational change in science.
Source: YaleNews
6 Jun 2019
News
WHRY funds study to enable early detection, treatment of ovarian cancer
Women’s Health Research at Yale (WHRY) is funding a study to explain how well-known genetic mutations can lead to ovarian cancer.
15 May 2018
News
Twenty years and counting for Women's Health Research at Yale
Women’s Health Research at Yale (WHRY), a self-supporting center within Yale School of Medicine, will celebrate its 20th anniversary in February. With data developed through $5 million in WHRY grants to date, Yale scientists have gone on to secure $95 million in external grants to further their research into women’s health.
Source: Medicine@Yale
21 Dec 2017
News
The Way Forward
When it comes to life-threatening diseases, people understandably want to maximize their chances for survival. So when considering the best practices to check for breast cancer, it makes intuitive sense that doctors and patients would prefer to screen early and often.
7 Apr 2016
News
Searching for Clarity Among Conflicting Breast Cancer Screening Guidelines
While guidelines offer slight disagreements about whether women should begin annual screening mammograms at a certain age, experts stress that recommendations have more in common than not.
26 Jan 2016
News
The Gift of Life: How a daughter’s generosity allowed a mother’s love to live on
Ann Baker Pepe embraced her mother’s attitude about helping others when she and her husband, Greg Pepe, donated to WHRY.
8 Dec 2015
News
Community Foundation Supports Women’s Health Research
Women’s Health Research at Yale has been awarded a three-year grant from The Community Foundation for Greater New Haven to support heart and cancer research.
24 Nov 2015
News
Health Headlines: How your age affects healthcare screenings
In today’s health headlines, how your age affects the kind of healthcare and screenings your doctor recommends as you get older. Radiation oncologist at Yale Cancer Center and Smilow Cancer Hospital, and Professor of Therapeutic Radiology at Yale School of Medicine, Dr. Suzanne Evans, is discussing this topic.
Source: WTNH
3 Feb 2023
News
Age 70 means a big change in breast cancer care, study finds
The year when a breast cancer patient turns 70 can make a big difference in the kind of treatment her doctor recommends, according to a study published in the International Journal for Radiation Oncology, Biology, Physics.
Source: AXIOS
1 Feb 2023
News
Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.
1 Feb 2023
News
Gap Discovered in Breast Cancer Radiotherapy Recommendations for Patients Aged 70 vs 69 Years
Age-based heuristics may lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new study published by Talcott et al in the International Journal of Radiation Oncology, Biology, and Physics.
Source: The ASCO Post
1 Feb 2023
News
Raise Your Voice About Your Metastatic Breast Cancer
Breast cancer is a common diagnosis for women of all races. But there are differences along racial lines when it comes to early detection, treatment, and survival rates.
Source: WEBMD
13 Jan 2023
News
HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact
Should breast cancer patients with low but not negative tumor expression of HER2 be considered a distinct patient group that can be treated differently from patients with tumors that are HER2 negative or HER2 positive? That was the question posed during a session at the recent San Antonio Breast Cancer Symposium (SABCS) 2022.
Source: Medscape
5 Jan 2023
News
New Treatments Keeping Women Alive Longer Through Breast Cancer
Five percent of women diagnosed with breast cancer have metastatic disease, but survival rates are climbing. According to the Breast Cancer Research Foundation, the number of women living with metastatic breast cancer rose to 168,000 last year from 155,000 the year before. New breakthroughs keep women alive longer while researchers race to find the next therapy that will work.
Source: WINK
19 Dec 2022
News
‘This is About Saving Women’s Lives’: Find It Early Act Aims to Increase Breast Cancer Screenings
Congresswoman Rosa DeLauro announced the introduction of the Find It Early Act which, if passed, would require insurance companies to cover mammograms, breast ultrasounds, and MRIs to increase early cancer detection.
13 Dec 2022
News
Patient Selection for AstraZeneca, Daiichi Breast Cancer Drug Needs Improvement, Experts Say
The rush to use AstraZeneca and Daiichi-Sankyo’s drug Enhertu to treat certain types of breast cancer has far outpaced doctors’ ability to determine with certainty which patients might benefit, experts said this week at a meeting of breast cancer doctors.
Source: Financial Post
9 Dec 2022
News
SABCS Data Solidifies Enhertu as Preferred Second-, Third-Line HER2-Positive Breast Cancer Treatment
SAN ANTONIO – Two Phase II trials of Daiichi Sankyo and AstraZeneca's Enhertu
Source: Precision Oncology News
8 Dec 2022
News
Panel to Examine the Ongoing Evolution of Antibody Drug Conjugates in the Treatment of Breast Cancer
Antibody drug conjugates (ADCs), which use a targeted monoclonal antibody to deliver a cytotoxic payload, are among the most effective breast cancer therapies yet developed. The first Food and Drug Administration approval of an ADC in breast cancer, ado-trastuzumab emtansine, better known as T-DM1, sparked development of numerous new and promising ADCs for breast cancer.
Source: SABCS Meeting News
7 Dec 2022